Clinical Trials Browser

Not yet recruiting × Inotuzumab Ozogamicin × 30 days × Clear all

NCT07476729 2026-03-17

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

Phase 3 Not yet recruiting

Burkitt Lymphoma